Sacral neuromodulation in patients with detrusor underactivity: Is biological sex an indicator?

Sacral neuromodulation in patients with detrusor underactivity: Is biological sex an indicator?


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: سنا طیبی , هانیه صالحی پورمهر , الهام جهان تابی , سکینه حاج ابراهیمی , چنگیز ناصری یالقوزآغاجی

کلمات کلیدی: detrusor underactivity, outcome, sacral neuromodulation, underactive bladder

نشریه: 25284 , 3 , 41 , 2022

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله سکینه حاج ابراهیمی
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات پزشکی مبتنی بر شواهد EBM
کد مقاله 78364
عنوان فارسی مقاله Sacral neuromodulation in patients with detrusor underactivity: Is biological sex an indicator?
عنوان لاتین مقاله Sacral neuromodulation in patients with detrusor underactivity: Is biological sex an indicator?
ناشر 8
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Objectives: This study aimed to report sacral neuromodulation (SNM) outcomes in detrusor underactivity (DU). Methods: A multicentric, multinational, retrospective case series was conducted between March 2017 and June 2021 in three different referral centers. Initial test phase stimulation included either a percutaneous nerve evaluation (PNE) or an advanced lead evaluation test phase (ALTP) before permanent SNM implantation. The test phases were performed under local anesthesia, either in the outpatient (PNE) or operating room (ALTP), in the prone position, which was implanted in the third or fourth sacral foramina under fluoroscopic guidance. Patients with favorable response to the initial test phase during the first 2 weeks underwent the implantable pulse generator (IPG) implantation (Medtronic neurostimulation generator device InterStim™). Favorable response was defined as ≥ 50% improvement in symptoms, frequency of clean intermittent catheterization (CIC) and/ or decrease in postvoid residual (PVR), increase in voided volume, or improvement in bladder voiding efficiency (BVE) based on the bladder diary. Results: Fifty‐eight patients were recruited with a mean age of 39.95 ± 15.28 years. Among the 58 cases, 36 (62.1%) patients responded to the initial stage. Of these, 12 patients (30.8%) with non‐neurogenic etiology and nine patients (52.9%) with neurologic etiology did not respond to the initial test phase; thus, they did not undergo full implantation (p = 0.141). Voided volume, PVR, and the median maximum flow rate (Qmax) improved significantly (p < 0.001) in both sexes; however, there was no statistical difference between both genders. Most female cases (78.3%), and nearly half of the men (51.4%), responded to the test phase and were candidates for the IPG phase. Among the 35 cases who underwent IPG, 27 patients (72.2% of males, and 77.8% of females; p = 0.700) had a favorable response to IPG. 46.6% of patients had a successful outcome at the end of the study. Conclusion: This multicentric study showed that SNM effectively and safely provided symptom improvement in refractory DU in males similar to females which is an important finding as previously it has been suggested that SNM works better in nonobstructive urinary retention in women and not in women.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
سنا طیبیدوم
هانیه صالحی پورمهرسوم
الهام جهان تابیچهارم
سکینه حاج ابراهیمیهفتم
چنگیز ناصری یالقوزآغاجیششم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
SNM-1-6.pdf1401/01/061245043دانلود